The preferred and most widely examined between selective androgen receptor modulators (SARMs), Ostarine —also called MK-2866, GTX 024, or Enobosarm —arrived within the scene again during the late 1990s being an experimental remedy for osteoporosis and particular diseases that cause insulin resistance, muscle wasting, and muscle loss.During the